Shareholders who are eligible to vote can vote:

(a) in person – by attending the Scheme Meeting and bringing your personalised admission card (Voting/Proxy Form which accompanies this Scheme Booklet). Scheme Meeting will be held at MUFG Pension & Market Services, Level 30, PwC Tower, 15 Customs Street West, Auckland, New Zealand;

(b) postal vote – by submitting a postal vote (which can be done online);

(c) attending meeting online – at www.virtualmeeting.co.nz/cvtsm25. Information on attending online, how to ask questions and vote, is available in the virtual meeting guide at mail.cm.mpms.mufg.com/MUFG/MUFG_ VirtualMeetingGuide.pdf;

(d) by proxy – by completing, signing and lodging the Proxy Form in accordance with the instructions on that form (which can be done online); or

(e) by corporate representative – a company (or limited partnership or incorporated society) which is a Shareholder may appoint a person to attend the Scheme Meeting on its behalf in the same manner as that in which it could appoint a proxy.

How to Appoint a Proxy

You may appoint a proxy to attend, and vote at, the Scheme Meeting on your behalf. If you wish to appoint a proxy, you must ensure that MPMS receives your completed Voting/ Proxy Form by no later than 2.00pm on Wednesday, 12 November 2025. You can submit your completed Voting/Proxy Forms:

(a) online: at MPMS’s website by following the instructions on the website https://nz.investorcentre.mpms.mufg.com/voting/CVT. You will be required to enter your Holder Number (CSN/HRN) and Authorisation Code (FIN) for security purposes

(b) by email: meetings.nz@cm.mpms.mufg.com (please use “Comvita Scheme Proxy Form” as the subject for easy identification)

(c) by mail: MUFG Pension & Market Services PO Box 91976 Auckland 1142 New Zealand

(d) in person: MUFG Pension & Market Services Level 30, PwC Tower 15 Customs Street
West Auckland 1010 New Zealand

If you appoint a proxy, you can either direct your proxy how to vote or let them decide on your behalf by ticking the box marked “discretion”. If you do not tick a box for the Scheme Resolution, then your proxy will be treated as having discretion on how to vote.
A proxy need not be a Shareholder. You may, if you wish, appoint the Chair or any other Director as your proxy. The Chair and all other Directors intend to vote undirected proxies in favour of the Scheme Resolution unless the Directors have changed their recommendation prior to the Scheme Meeting, in which case the Chair and all other Directors of Comvita will vote all undirected proxies against the Scheme Resolution.

If, in appointing a proxy, you have not named a person to be your proxy, or your named proxy does not attend the Scheme Meeting, the Chair of the meeting will be your proxy and will vote in accordance with your express direction. If you have not included an express direction, the Chair will exercise your vote in favour of the Scheme unless the Directors have changed their recommendation prior to the Scheme Meeting, in which case the Chair of the Scheme Meeting will vote undirected proxies against the Scheme.

MPMS has been authorised by the Comvita Board to receive and count postal votes at the Scheme Meeting.

Once appointed, a proxy can be revoked or your voting directions to your proxy can be changed by lodging a new proxy online as set out in the Procedural Notes above, or by giving written notice to the address details set out in above provided that such notice is received before 2.00pm on Wednesday, 12 November 2025. If you attend the Scheme Meeting in person or online you may, but are not required to, revoke your proxy.

Comvita may in its discretion accept proxy appointments received after 2.00pm on Wednesday, 12 November 2025 if it considers it to be in the best interests of Comvita and Shareholders as a whole.

Attending the Scheme Meeting Online

Shareholders who choose to attend the Scheme Meeting virtually online (via MPMS’s virtual meeting platform at www.virtualmeeting.co.nz/cvtsm25) will be able to watch the meeting, vote and ask questions using their smartphone, tablet or desktop device.

Shareholders will require a valid email address to access the meeting and will need their Shareholder number to ask questions and vote.

For more information, please refer to the virtual meeting guide available here: mail.cm.mpms.mufg.com/MUFG/MUFG_ VirtualMeetingGuide.pdf

If you have a question for the Chair of the Scheme Meeting

Shareholders who are eligible to vote can ask questions of the Chair / CEO prior to the Scheme Meeting in writing as set out below. Comvita has discretion as to which, and how, questions will be answered during the Chair’s address at the Scheme Meeting.
(a) online: nz.investorcentre.mpms.mufg.com/voting/ CVT – you will be required to enter your holder number CSN/Holder Number and Authorisation Code (FIN) for security purposes;

(b) by Voting/Proxy Form: Complete the shareholder question section on the Voting/Proxy Form and return it to MPMS

(c) by email: meetings.nz@cm.mpms.mufg.com – (please use “Comvita Scheme Question” as the subject for easy identification)

(d) by mail: MUFG Pension & Market Services PO Box 91976 Auckland 1142 New Zealand

There will also be an opportunity for Shareholders to raise questions during the Scheme Meeting in person or through the online platform at www.virtualmeeting.co.nz/cvtsm25.

If you are not in favour of the Scheme

If you are not in favour of the Scheme, you can vote against it at the Scheme Meeting (in person, by postal vote, online vote, by proxy or by corporate representative). As a Shareholder, you also have the right to appear and be heard at the Final Court Hearing. You will need to file a notice with the Court. Further details are set out in section 3.17.

If you do not want to participate in the Scheme, you are free to sell your Comvita Shares at any time before trading in Comvita Shares is suspended in anticipation of the implementation of the Scheme (expected to be the date which is three Business Days before the Scheme Record Date).